Skip to main content
Equibles
ACAD logo

ACAD · Acadia Pharmaceuticals Inc

Track ACAD — free

Use ACAD with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

Claude ChatGPT Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$28.02 +0.16 (+0.57%) At close · Sep 4
S&P 600 member Russell 2000 member Rebalance outlook locked
Market Cap
$4.83B
Shares
172.31M

ACAD metrics

74 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$28.02
Market cap
$4.83B

Price action

19 metrics
Price change (1W)
-3.7%
Price change (30D)
-4.1%
Price change (3M)
+30.0%
Price change (6M)
+26.4%
Price change (YTD)
+4.9%
Price change (1Y)
+9.9%
Trailing year
Price change (5Y)
+67.0%
52-week high
$30.57
52-week low
$20.06
Change from 52-week high
-8.3%
Change from 52-week low
+39.7%
Annualized volatility
38.2%
Beta
0.9
RSI (14D)
47.1
Price vs SMA 50
+2.7%
Price vs SMA 200
+14.5%
Avg volume (3M)
1.63M
Relative volume
1.0
Average dollar volume
$42.89M

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
172.31M

Valuation

12 metrics
P / E (TTM)
12.6
Trailing earnings · reciprocal yield 8.0%
PEG ratio
1.0
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
4.3×
reciprocal yield 23.5%
P / book
3.7
reciprocal yield 27.0%
FCF yield
3.0%
TTM · current market cap
Buyback yield
—
P / FCF
33.3
reciprocal yield 3.0%
P / operating cash flow
30.2
reciprocal yield 3.3%
Earnings yield
7.9%

Historical valuation

8 metrics
P / E historical average (3Y)
13.2×
reciprocal yield 7.5%
P / E historical average (5Y)
13.2×
reciprocal yield 7.5%
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-04

Profitability

9 metrics
Gross margin
—
Operating margin
7.6%
Trailing 12 months
Net margin
33.4%
Gross profit (TTM)
$684.80M
Operating profit (TTM)
$86.37M
Net income (TTM)
$380.48M
Trailing 12 months
Diluted EPS (TTM)
$2.23
FCF margin
12.8%
Effective tax rate
-213.5%

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$0.75

Growth

11 metrics
Revenue growth YoY
+16.4%
Year over year
Net income growth YoY
+18.1%
Revenue (TTM)
$1.14B
Trailing 12 months
EPS growth YoY
+12.5%
Shares change YoY
+2.5%
Year over year · more shares
Revenue CAGR (3Y)
+27.5%
Revenue CAGR (5Y)
+19.4%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
29.1%
Return on assets
21.8%
Debt / equity
—
Current ratio
3.4
EBITDA (TTM)
—
Free cash flow (TTM)
$145.62M
Quick ratio
3.1
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$384.99M
Total assets
$1.74B
Total debt
$22,000

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$160.32M
Capital expenditures (TTM)
$14.69M
R&D (TTM)
$331.01M
SG&A (TTM)
$620.29M
Stock compensation (TTM)
$58.05M
R&D / revenue
29.1%
Stock compensation / revenue
5.1%

Ownership (13F)

3 metrics
13F filers
355
13F filer change QoQ
+8
Institutional ownership
98.2%

Short interest

3 metrics
Short interest
5.5%
Latest settlement · 4.5 days to cover
Days to cover
4.5d
Short-squeeze score
55 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$1.32M
Insider-sentiment score
46 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1070494 CUSIP 004225108 13F (30d) 219 filings 218 filers Visit website Investor relations